Literature DB >> 34004061

Identification of immune-activating metabolite for enhancing T cell therapy of cancer.

Boyi Cong1, Zenghui Cui1, Xuetao Cao1,2.   

Abstract

In this Research Highlight, we summarized the results from a study by Wu et al. published in Nature Cell Biology which uncovered that asparagine (Asn), a non-essential amino acid in mammalians, is able to enhance the TCR-mediated activation and efficacy of CD8+ T cells towards tumour through lymphocyte-specific protein tyrosine kinase (LCK) signalling. This study provides insights into the physiological function of Asn in T cell activation and effector functions, showing the encouraging possibility of key metabolites for empowering cancer immunotherapy.
© 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat-sen University Cancer Center.

Entities:  

Year:  2021        PMID: 34004061     DOI: 10.1002/cac2.12177

Source DB:  PubMed          Journal:  Cancer Commun (Lond)        ISSN: 2523-3548


  1 in total

1.  Transcriptional suppression of CD8+ T cell exhaustion for improving T cell immunotherapy.

Authors:  Xue Yang; Bingjing Wang; Xuetao Cao
Journal:  Cancer Commun (Lond)       Date:  2021-09-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.